Clinical Pearls Podcasts

MediCom Oncology Clinical Pearls Podcasts provide practical, evidence-based recommendations on real-world issues in the clinical setting. For more tips and advice on best practices in patients, subscribe to our channel on iTunes.

What are the pros and cons of radiation therapy?

Matthew Matasar, MD

Clinical Pearls Podcasts published on December 7, 2017

What defines high-quality survivorship care for patients treated for classical Hodgkin lymphoma?

Matthew Matasar, MD

Clinical Pearls Podcasts published on November 6, 2017

What may be the future role for brentuximab vedotin in newly diagnosed Hodgkin lymphoma?

Matthew Matasar, MD

Clinical Pearls Podcasts published on October 23, 2017

How does the safety profile of the new and emerging anti-PD 1 antibodies differ from chemotherapy?

Alison J. Moskowitz, MD

Clinical Pearls Podcasts published on July 11, 2017

Is the AE profile of BV the same or different from traditional monoclonal antibody therapies?

Alison J. Moskowitz, MD

Clinical Pearls Podcasts published on May 10, 2017

What are some of the more common adverse reactions associated with brentuximab vedotin and how are they most often managed?

Alison J. Moskowitz, MD

Clinical Pearls Podcasts published on April 7, 2017

The new FDA approval of pembrolizumab for cHL

Anas Younes, MD

Clinical Pearls Podcasts published on March 22, 2017

Results 1 - 7 of 7

Clinical Pearls Podcasts

MediCom Worldwide, Inc. Links